S 18986

Drug Profile

S 18986

Alternative Names: S 18986-1; S18986

Latest Information Update: 09 Dec 2010

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Cortex Pharmaceuticals
  • Developer Servier
  • Class Antidementias; Benzothiadiazines; Neuroprotectants; Nootropics; Small molecules
  • Mechanism of Action AMPA receptor modulators; Central nervous system stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Suspended Cognition disorders

Most Recent Events

  • 15 Nov 2010 Suspended - Phase-II for Cognition disorders in France (PO)
  • 07 Nov 2007 Pharmacodynamics data from a preclinical trial in cognitive impairment presented at the 37th Annual Meeting of the Society for Neuroscience (SFN-2007) ,
  • 29 Jul 2004 Pharmacodynamics and pharmacokinetics data presented at the 9th International Conference on Alzheimer's Disease and Related Disorders (ICAD-2004) ,,
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top